|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.200 USD | -4.35% |
|
-4.35% | -36.42% |
| 04-23 | Grace Therapeutics Shares Fall After FDA Flags Issues in Aneurysm Treatment Application | DJ |
| 04-23 | FDA declines Grace's stroke drug over manufacturing and packaging issues, shares slump | RE |
| Market Cap | 47.53M 33.95M 29.38M 27.05M 25.34M 3.23B 48.27M 321M 124M 1.57B 128M 125M 5.44B | P/E Ratio 2026 * |
-2.99x | P/E Ratio 2027 * | -3.23x |
|---|---|---|---|---|---|
| Enterprise Value | 47.53M 33.95M 29.38M 27.05M 25.34M 3.23B 48.27M 321M 124M 1.57B 128M 125M 5.44B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
72.94% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -4.35% | ||
| 1 week | -4.35% | ||
| Current month | -14.40% | ||
| 1 month | -5.58% | ||
| 3 months | -45.81% | ||
| 6 months | -33.53% | ||
| Current year | -36.42% |
| 1 week | 2.16 |  | 2.4 |
| 1 month | 2.08 | | 2.71 |
| Current year | 1.79 | | 5.18 |
| 1 year | 1.79 | | 5.18 |
| 3 years | 1.72 | | 5.18 |
| 5 years | 1.72 | | 32.64 |
| 10 years | 1.72 | | 161.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 54 | 2023-04-03 |
| Director of Finance/CFO | 54 | 2024-01-04 | |
Robert Macdonald
CTO | Chief Tech/Sci/R&D Officer | 64 | 2023-05-07 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | - | |
Prashant Kohli
BRD | Director/Board Member | 54 | 2023-04-03 |
A. Davis
BRD | Director/Board Member | 59 | 2023-10-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-11 | Option | Director | 10,000 | 0.0646% | ||
| 01-11 | Option | Chairman | 10,000 | 0.0646% | ||
| 01-11 | Option | Director | 10,000 | 0.0646% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.35% | -4.35% | -24.66% | -25.79% | 34.04M | |
| +1.03% | +2.30% | +54.92% | +111.78% | 56.42B | |
| +2.72% | +3.26% | +47.26% | +47.26% | 44.54B | |
| +1.12% | +2.79% | -13.71% | -17.53% | 22.9B | |
| +1.17% | +3.85% | +1.00% | +401.79% | 21.21B | |
| +3.81% | -5.07% | +12.00% | -29.52% | 16.4B | |
| +0.15% | +2.24% | +9.10% | -40.04% | 15.4B | |
| -0.69% | +0.82% | +27.17% | +178.31% | 13.35B | |
| +5.27% | +5.54% | +14.25% | - | 12.36B | |
| +1.61% | +1.28% | +92.88% | +215.31% | 11.15B | |
| Average | +1.18% | +1.45% | +22.02% | +93.51% | 21.38B | |
| Weighted average by Cap. | +1.72% | +2.36% | +31.91% | +100.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -18.68M -13.34M -11.54M -10.63M -9.96M -1.27B -18.97M -126M -48.88M -618M -50.1M -49.03M -2.14B | -20.52M -14.66M -12.69M -11.68M -10.94M -1.39B -20.84M -139M -53.71M -679M -55.06M -53.88M -2.35B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 2.200 $ | -4.35% | 412,679 |
| 26-06-11 | 2.300 $ | -0.43% | 223,148 |
| 26-06-10 | 2.310 $ | -0.86% | 133,603 |
| 26-06-09 | 2.330 $ | +1.30% | 151,683 |
| 26-06-08 | 2.300 $ | 0.00% | 165,880 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GRCE Stock
Select your edition
All financial news and data tailored to specific country editions
